3. The International Study of Asthma and Allergies in Chidhood(ISAAC)steering committee:worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema:ISAAC Lancet. 351:1225-1232, 1998.
3. N Sigurs, R Bjarnason, F Sigurbergsson, et al:Asthma and Immunoglobulin E Antibodies After Respiratory Syncytial Virus Bronchiolitis:A Prospective Cohort Study With Matched Controls. Pediatrics. 95:500-505, 1995
2. Wieslander G, Norback D, Bjornsson E, et al. Asthma and the indoor environment. the significance of emission of formaldehyde and volatile organic compounds from newly painted indoor surface. International Archives of Occpational & Envionmental Health 69:115-124, 1997
1. J Nakano, MK Ohta, et al:Prevalence of bronchial asthma in adults in Japane-epidemiologic studies of asthma in Fujieda city in 1985 and 1999-American Joumal of respiratory and critical care medicine. 161:A798, 2000
5. Behbehani NA, Al-Mane F, D'Yachkova Y, Pare P, FitzGerald JM:Myopathy following mechanical ventilation for acute sever asthma:the role of muscle relaxants and corticosteroids. Chest 115:1627-31, 1999
4. Eickelberg O, Roth M, Lorx R, et al:Ligand-independent activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem. 274:1005-1010, 1999